NCBI PubMed Central
open access
Colorectal neuroendocrine neoplasm organoids reveal the potential therapeutic value of targeting BRAF mutations.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prognostic value of Lynch syndrome, BRAF V600E , and RAS mutational status in dMMR / MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts#326134
- Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery.#1336
- Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions#865904
- Combination Therapy for BRAF-V600E Metastatic CRCm#1059781
- A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers#812603
Record · ID 653461
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive